JHIU
DMTX

Janus Henderson Investors US’s Dimension Therapeutics, Inc DMTX Stock Holding History

Janus Henderson Investors US’s Portfolio DMTX Stock Details DMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,106,781
Closed -$4.82M – 1251
2016
Q4 		$4.82M Sell
1,106,781
-60,132
-5% -$320K ﹤0.01% 847
2016
Q3 		$9.32M Sell
1,166,913
-10,252
-0.9% -$74.1K 0.01% 708
2016
Q2 		$7.06M Buy
1,177,165
+2,628
+0.2% +$20K 0.01% 723
2016
Q1 		$9.2M Sell
1,174,537
-38,086
-3% -$300K 0.01% 677
2015
Q4 		$13.7M Buy
+1,212,623
New +$15.3M 0.01% 664

Other funds holding DMTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Janus Henderson Investors US's DMTX Position: Q1 2017 in Review

Janus Henderson Investors US sold out of Dimension Therapeutics, Inc (DMTX) in Q1 2017, closing a stake of 1,106,781 shares — an estimated $4.82M sold.

Janus Henderson Investors US first reported a position in DMTX in Q4 2015 and held it in 5 quarters. The position peaked at $13.7M in Q4 2015. 47 funds tracked by Wall St. Rank hold DMTX as of Q1 2017.

  • Janus Henderson Investors US reported no remaining Dimension Therapeutics, Inc position as of Q1 2017 after selling out during the quarter.
  • Janus Henderson Investors US sold 1,106,781 Dimension Therapeutics, Inc shares in Q1 2017, an estimated $4.82M.
  • Janus Henderson Investors US first reported a position in Dimension Therapeutics, Inc in Q4 2015 and held it in 5 quarters.
  • Janus Henderson Investors US's Dimension Therapeutics, Inc position peaked at $13.7M in Q4 2015.
  • 47 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.